S-Target Therapeutics Gmbh

Calculating rank

USPTO Granted Patents = 3

EPO Patents = 2

Forward Citations = 4

Loading Chart...

2 inventors (with patents filed for the assignee):

Geert Mudde (3 out of 15 patents)

Gottfried Himmler (2 out of 24 patents)

3 patents: Sort by Forward Citations

1. 10434170 - Immunoregulatory vaccine (2019-10-08),

2. 10189905 - Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies (2019-01-29),

3. 9636415 - Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies (2017-05-02),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

3 Patents

#172 in Vienna

#761 in Austria

Vienna, Austria

S-Target Therapeutics Gmbh

Forward Citations = 4

2 inventors:

Geert Mudde (3 out of 15 patents)

Gottfried Himmler (2 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: S-Target Therapeutics Gmbh. Retrieved from https://idiyas.com/company/s-target-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]